Cargando…
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia
Since the serendipitous discovery of cisplatin, platinum-based drugs have become well-established antitumor agents, despite the fact that their clinical use is limited by many severe side-effects. In order to both improve the chemotherapeutic index and broaden the therapeutic spectrum of current dru...
Autores principales: | Nardon, Chiara, Schmitt, Sara M., Yang, Huanjie, Zuo, Jian, Fregona, Dolores, Dou, Q. Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879379/ https://www.ncbi.nlm.nih.gov/pubmed/24392119 http://dx.doi.org/10.1371/journal.pone.0084248 |
Ejemplares similares
-
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells
por: Dalla Pozza, Maria, et al.
Publicado: (2021) -
Gold(III)–pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents**
por: Nardon, Chiara, et al.
Publicado: (2015) -
Pyroptosis at the forefront of anticancer immunity
por: Loveless, Reid, et al.
Publicado: (2021) -
Procurement at the forefront of technology
por: Unnervik, Anders
Publicado: (2018) -
USA ' Forefront ' programme
Publicado: (1983)